RT @sitcancer: #JITC Research: A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V6…
438 followers
19,232 followers
#JITC Research: A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma https://t.co/oARaSUVj2y https://t.co/wntR7jD3CA
438 followers
RT @sitcancer: #JITC Research: A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V6…
19,232 followers
#JITC Research: A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma https://t.co/oARaSUVj2y https://t.co/LM2W8DdtBF